Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q1 FY27

Dhanuka Agritech Q1 FY27 Results: Net Profit ₹36.3 Cr, Down 34.6% YoY

Dhanuka Agritech Ltd reported revenue from operations of ₹461.9 Cr (-12.6% YoY) and net profit of ₹36.3 Cr (-34.6% YoY) for Q1 FY27.

Q1 FY27 at a glance · ₹ crore
MetricQ1 FY27Q4 FY26Q1 FY26
Revenue from operations461.9483.3528.3
Other income8.920.58.0
Total income470.8503.9536.3
Profit before exceptional items & tax48.6128.374.5
Profit before tax48.6128.374.5
Net profit36.397.855.5
Operating margin10.3%25.5%13.9%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Net profit, year on year-34.60%
Net profit, quarter on quarter-62.90%
Revenue, year on year-12.60%
Operating profit, year on year-42.30%
Operating profit, quarter on quarter-64.60%
Source

BSE results filing, NSE: DHANUKA. Figures extracted from the filing.

Read the filing ↗

Dhanuka Agritech Ltd: key numbers

Share price
₹964.35
Market cap
₹4,347 Cr
Revenue (annual)
₹2,020 Cr
Net profit (annual)
₹287.2 Cr
Promoter holding
69.81%+0.10% QoQ
FII holding
1.64%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Dhanuka Agritech Ltd

All →
19:58 IST NSE
Product Launch

Dhanuka Agritech Product Launch

Dhanuka Agritech has launched 'POLIN', a new fungicide, in the domestic Indian market. This product features a novel mode of action for enhanced crop protection.

16:10 IST BSE
Credit Rating

Dhanuka Agritech Credit Rating

CARE Ratings reaffirmed Dhanuka Agritech's bank facilities at 'CARE AA; Stable' and 'CARE A1+'. These ratings assess the company's financial and operational performance.

16:00 IST BSE
Employee Stock Options

Dhanuka Agritech Employee Stock Options

Dhanuka Agritech Limited received in-principle approval from NSE and BSE to list up to 50,000 equity shares issued under its ESOP 2026 scheme.